子痫前期定义对疾病诊断和结局的影响:一项回顾性队列研究
该回顾性队列研究纳入2016年1月1日至2018年7月31日Monash Health的单胎妊娠,按ISSHP 2001、ACOG 2018和ISSHP 2018标准重新分类子痫前期。采用更宽泛定义后子痫前期诊断率增加,但仅符合新标准的妇女疾病表型较轻。
要点
- 采用ACOG 2018或ISSHP 2018标准较ISSHP 2001标准可多诊断子痫前期。
- 仅符合ISSHP 2018新增标准的妇女病情较轻,严重高血压和硫酸镁使用率更低。
- 客观指标(胎儿生长受限、血小板减少、肾肝损伤、蛋白尿)与不良结局风险增加相关。
核心结论
- 采用更宽泛的子痫前期定义会增加疾病诊断率,但仅符合新标准的妇女表型较轻,是否改善结局仍不确定。
研究设计与样本
- 回顾性队列研究,纳入2016年1月1日至2018年7月31日Monash Health的单胎妊娠,共22,094例妊娠,其中751例(3.4%)符合任一标准诊断子痫前期。
主要发现
- ACOG 2018标准较ISSHP 2001标准额外识别42例子痫前期(654例 vs 696例,相对增加6.4%)。
- ISSHP 2018标准较ISSHP 2001标准额外识别97例子痫前期(654例 vs 751例,相对增加14.8%)。
- ISSHP 2018额外识别的妇女疾病较轻:严重高血压发生率62.4% vs 44.3%(P<.01),硫酸镁使用率11.9% vs 4.1%(P<.05),不良母体结局有更低趋势(9.8% vs 4.1%)。
- 这些妇女分娩孕周更晚,新生儿重症监护 admission 和不良围产结局更少。
- 客观特征如胎儿生长受限、血小板减少、肾和肝损伤及蛋白尿与不良母体和围产结局风险增加相关,而主观神经系统特征关联较差。
关键数值与推荐
- 子痫前期诊断标准包括ISSHP 2001、ACOG 2018和ISSHP 2018。
- ISSHP 2018额外识别的妇女严重高血压发生率44.3% vs ISSHP 2001组62.4%(P<.01)。
- ISSHP 2018额外识别的妇女硫酸镁使用率4.1% vs ISSHP 2001组11.9%(P<.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnostic criteria for preeclampsia have evolved from the traditional definition of de novo hypertension and proteinuria to a broader definition of hypertension with evidence of end-organ dysfunction. Although this change is endorsed by various societies such as the International Society for the Study of Hypertension in Pregnancy and the American College of Obstetricians and Gynecologists, there remains controversy with regard to the implementation of broader definitions and the most appropriate definition of end-organ dysfunction. OBJECTIVE: This study aimed to assess the impact of different diagnostic criteria for preeclampsia on rates of disease diagnosis, disease severity, and adverse outcomes and to identify associations between each component of the different diagnostic criteria and adverse pregnancy outcomes. STUDY DESIGN: We performed a retrospective cohort study of singleton pregnancies at Monash Health between January 1, 2016 and July 31, 2018. Within this population, all cases of gestational hypertension and preeclampsia were reclassified according to the International Society for the Study of Hypertension in Pregnancy 2001, American College of Obstetricians and Gynecologists 2018, and International Society for the Study of Hypertension in Pregnancy 2018 criteria. Differences in incidence of preeclampsia and maternal and perinatal outcomes were compared between the International Society for the Study of Hypertension in Pregnancy 2001 group and the extra cases identified by American College of Obstetricians and Gynecologists 2018 and International Society for the Study of Hypertension in Pregnancy 2018. Outcomes assessed included biochemical markers of preeclampsia, a composite of adverse maternal outcomes, and a composite of adverse perinatal outcomes. Multiple logistic regression analysis was also performed to assess each component of the American College of Obstetricians and Gynecologists 2018 and International Society for the Study of Hypertension in Pregnancy 2018 criteria and their associations with adverse maternal and perinatal outcomes. RESULTS: Of 22,094 pregnancies, 751 (3.4%) women had preeclampsia as defined by any of the 3 criteria. Compared with International Society for the Study of Hypertension in Pregnancy 2001, the American College of Obstetricians and Gynecologists 2018 criteria identified an extra 42 women (n=654 vs n=696, 6.4% relative increase) with preeclampsia, and International Society for the Study of Hypertension in Pregnancy 2018 identified an extra 97 women (n=654 vs n=751, 14.8% relative increase). The additional women identified by International Society for the Study of Hypertension in Pregnancy 2018 exhibited a milder form of disease with lower rates of severe hypertension (62.4% vs 44.3%; P<.01) and magnesium sulfate use (11.9% vs 4.1%; P<.05) and a trend toward lower rates of adverse maternal outcomes (9.8% vs 4.1%). These women also delivered at a later gestation, and their babies had a lower number of neonatal intensive care unit admissions and adverse perinatal outcomes. Objective features such as fetal growth restriction, thrombocytopenia, renal and liver impairment, and proteinuria were associated with an increased risk of adverse maternal and perinatal outcomes, whereas subjective neurologic features demonstrated poorer associations. CONCLUSION: Implementation of broader definitions of preeclampsia will result in an increased incidence of disease diagnosis. However, because women who exclusively fulfill the new criteria have a milder phenotype of the disease, it remains uncertain whether this will translate to improved outcomes.
引用
- Reddy M, Fenn S, Rolnik DL, et al. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2020. PMID: 32795430. doi:10.1016/j.ajog.2020.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。